Source:http://linkedlifedata.com/resource/pubmed/id/15013333
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2004-3-11
|
pubmed:abstractText |
Posttransplantation erythrocytosis (PE) is a frequent problem in renal transplant patients. The pathogenesis and mechanisms of both the problem and therapy strategy are unknown. Since ACE and angiotensin 2 receptor inhibitors have been used to successfully manage PE, we speculated a relation between gene polymorphisms and this complication. Ninety-six ( 30 women, 66 men, age 34.4 +/- 11.0 years) renal transplant patients evaluated retrospectively, for gene polymorphisms of ACE, angiotensinogen, angiotensin 1 and 2 receptors (ATR1 and ATR2), as well as endothelial nitric oxide synthase (ecNOS). They were divided into two groups; patients with versus without PE, which was defined as >15 g/dL hemoglobin levels during the first year after renal transplantation. PE was found to be significantly more prevalent among D/D than I/I gene polymorphism of ACE genes (P <.04). The distribution of D/D, I/D, and I/I polymorphisms were 39.1%, 45.9%, and 7.6%, respectively. There was no difference between D/D and I/D polymorphisms. Comparing the I/D and I/I polymorphisms showed PE to be statistically more prevalent in the I/D polymorphism (P <.01). Logistic regression analysis revealed that D/D and I/D polymorphisms were significant risk factors for PE (P <.05, RR = 7.714 and P <.03, RR = 10.199, respectively). While previous studies revealed a relation between angiotensin II and PE, our study discovered the contribution of ACE gene polymorphism.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/NOS3 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide Synthase,
http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide Synthase Type III,
http://linkedlifedata.com/resource/pubmed/chemical/Peptidyl-Dipeptidase A,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Angiotensin, Type 1,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Angiotensin, Type 2
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0041-1345
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
36
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
161-3
|
pubmed:dateRevised |
2005-11-17
|
pubmed:meshHeading |
pubmed-meshheading:15013333-Adult,
pubmed-meshheading:15013333-Female,
pubmed-meshheading:15013333-Gene Frequency,
pubmed-meshheading:15013333-Humans,
pubmed-meshheading:15013333-Kidney Transplantation,
pubmed-meshheading:15013333-Male,
pubmed-meshheading:15013333-Nitric Oxide Synthase,
pubmed-meshheading:15013333-Nitric Oxide Synthase Type III,
pubmed-meshheading:15013333-Peptidyl-Dipeptidase A,
pubmed-meshheading:15013333-Polycythemia,
pubmed-meshheading:15013333-Polymorphism, Genetic,
pubmed-meshheading:15013333-Postoperative Complications,
pubmed-meshheading:15013333-Receptor, Angiotensin, Type 1,
pubmed-meshheading:15013333-Receptor, Angiotensin, Type 2,
pubmed-meshheading:15013333-Retrospective Studies
|
pubmed:articleTitle |
Angiotensin-converting enzyme gene polymorphism significantly affects renal posttransplantation erythrocytosis.
|
pubmed:affiliation |
Department of Nephrology, Ba?kent University School of Medicine, Ankara, Turkey.
|
pubmed:publicationType |
Journal Article
|